Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
Cunningham, David, Prof, Lang, Istvan, MD, Marcuello, Eugenio, MD, Lorusso, Vito, MD, Ocvirk, Janja, MD, Shin, Dong Bok, MD, Jonker, Derek, MD, Osborne, Stuart, MSc, Andre, Niko, MD, Waterkamp, Daniel, MD, Saunders, Mark P, MD
Published in The lancet oncology (01.10.2013)
Published in The lancet oncology (01.10.2013)
Get full text
Journal Article
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Pivot, Xavier, Prof, Gligorov, Joseph, MD, Müller, Volkmar, Prof, Barrett-Lee, Peter, Prof, Verma, Sunil, Prof, Knoop, Ann, MD, Curigliano, Giuseppe, MD, Semiglazov, Vladimir, Prof, López-Vivanco, Guillermo, MD, Jenkins, Valerie, DPhil, Scotto, Nana, MD, Osborne, Stuart, MSc, Fallowfield, Lesley, Prof
Published in The lancet oncology (01.09.2013)
Published in The lancet oncology (01.09.2013)
Get full text
Journal Article
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
Michallet, Anne-Sophie, Aktan, Melih, Hiddemann, Wolfgang, Ilhan, Osman, Johansson, Peter, Laribi, Kamel, Meddeb, Balkis, Moreno, Carol, Raposo, João, Schuh, Anna, Ünal, Ali, Widenius, Tom, Bernhardt, Alf, Kellershohn, Kerstin, Messeri, Dimitri, Osborne, Stuart, Leblond, Véronique
Published in Haematologica (Roma) (01.04.2018)
Published in Haematologica (Roma) (01.04.2018)
Get full text
Journal Article
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
Lugtenburg, Pieternella, Avivi, Irit, Berenschot, Henriette, Ilhan, Osman, Marolleau, Jean Pierre, Nagler, Arnon, Rueda, Antonio, Tani, Monica, Turgut, Mehmet, Osborne, Stuart, Smith, Rodney, Pfreundschuh, Michael
Published in Haematologica (Roma) (01.11.2017)
Published in Haematologica (Roma) (01.11.2017)
Get full text
Journal Article
HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study
Kim, Woo-Ho, Gomez-Izquierdo, Lourdes, Vilardell, Felip, Chu, Kent-Man, Soucy, Geneviève, Dos Santos, Lucas V, Monges, Geneviève, Viale, Giuseppe, Brito, Maria José, Osborne, Stuart, Noé, Johannes, Du, Xiang
Published in Applied immunohistochemistry & molecular morphology (01.04.2018)
Published in Applied immunohistochemistry & molecular morphology (01.04.2018)
Get more information
Journal Article
The use of a pre-operative scoring system for the prediction of phacoemulsification case difficulty and the selection of appropriate cases to be performed by trainees
Osborne, Stuart A, Severn, Phillip, Bunce, Catey V, Fraser, Scott G
Published in BMC ophthalmology (27.12.2006)
Published in BMC ophthalmology (27.12.2006)
Get full text
Journal Article
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
Lukas, Rimas V., Rodon, Jordi, Becker, Kevin, Wong, Eric T., Shih, Kent, Touat, Mehdi, Fassò, Marcella, Osborne, Stuart, Molinero, Luciana, O’Hear, Carol, Grossman, William, Baehring, Joachim
Published in Journal of neuro-oncology (01.11.2018)
Published in Journal of neuro-oncology (01.11.2018)
Get full text
Journal Article
Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive (fp) non-small cell lung cancer (NSCLC)
Cho, Byoung Chul, Chiu, Chao-Hua, Massarelli, Erminia, Buchschacher, Gary L, Goto, Koichi, Overbeck, Tobias R., Loong, Herbert H. F., Chee, Cheng E., Garrido, Pilar, Heinzmann, Sebastian, Bordogna, Walter, Zeuner, Harald, Osborne, Stuart, John, Tom
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Pharmacokinetics of pimecrolimus, a novel nonsteroid anti-inflammatory drug, after single and multiple Oral administration
SCOTT, Graham, OSBORNE, Stuart A, GREIG, Gerard, HARTMANN, Stefan, EBELIN, Marie-Eve, BURTIN, Pascale, RAPPERSBERGER, Klemens, KOMAR, Michael, WOLFF, Klaus
Published in Clinical pharmacokinetics (01.01.2003)
Published in Clinical pharmacokinetics (01.01.2003)
Get full text
Journal Article
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
Cho, Byoung Chul, Chiu, Chao-Hua, Massarelli, Erminia, Buchschacher, Gary L, Goto, Koichi, Overbeck, Tobias R, Loong, Herbert H F, Chee, Cheng E, Garrido, Pilar, Dong, Xiaorong, Fan, Yun, Lu, Shun, Schwemmers, Sven, Bordogna, Walter, Zeuner, Harald, Osborne, Stuart, John, Thomas
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2024)
Get full text
Journal Article
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer
Loupakis, Fotios, Hurwitz, Herbert I, Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef
Published in British journal of cancer (01.12.2018)
Published in British journal of cancer (01.12.2018)
Get full text
Journal Article
Abstract PS11-28: Efficacy and safety of entrectinib in NTRK fusion-positive ( NTRK -fp) breast cancer
Lu, Janice, Blakely, Collin M., Le Tourneau, Christophe, Waqar, Saiama N., Bauer, Todd M., de Braud, Filippo, Hong, David S., Spira, Alexander, Tan, Tira, McCallum, Samuel, Osborne, Stuart, Simmons, Brian, Barve, Minal
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Efficacy outcomes with bevacizumab added to chemotherapy (bev+CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC)
Loupakis, Fotios, Hurwitz, Herbert I., Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Yau, Linda, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial
Gligorov, Joseph, Curigliano, Giuseppe, Müller, Volkmar, Knoop, Ann, Jenkins, Valerie, Verma, Sunil, Osborne, Stuart, Lauer, Sabine, Machackova, Zuzana, Fallowfield, Lesley, Pivot, Xavier
Published in Breast (Edinburgh) (01.08.2017)
Published in Breast (Edinburgh) (01.08.2017)
Get full text
Journal Article
Efficacy and Safety of Subcutaneous or Intravenous Administration of Rituximab in Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Final Results of the Randomized, Open-Label, Crossover, PrefMab Study
Rummel, Mathias J, Kim, Tae Min, Aversa, Franco, Brugger, Wolfram, Capochiani, Enrico, Plenteda, Caterina, Re, Francesca, Task, Peter, McIntyre, Christine, Meier, Oliver, Osborne, Stuart, Smith, Rodney, Grigg, Andrew
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Abstract C149: Efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK or ROS1 fusion-positive (fp) solid tumors, not evaluable for the primary endpoint of STARTRK-2
Liu, Stephen V, Peeters, Marc, Ahn, Myung-Ju, Lin, Jessica J, Ohe, Yuichiro, Yau, Chung Cheung Thomas, Bordogna, Walter, Osborne, Stuart, Schwemmers, Sven, Zeuner, Harald, Goto, Koichi
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Rummel, Mathias, Kim, Tae Min, Plenteda, Caterina, Capochiani, Enrico, Mendoza, Maria, Smith, Rodney, Osborne, Stuart, Grigg, Andrew
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A Randomized Comparison Of Maintenance Therapy With Subcutaneous Rituximab For 2 Years Versus Until Progression In Patients With Indolent Non-Hodgkin's Lymphoma: Interim Safety Data From The Mabcute Study
Rule, Simon, Briones, Javier, Carella, Angelo Michele, Casasnovas, Olivier, Barreto, Wolney Gois, Pocock, Christopher, Osborne, Stuart, Smith, Rodney, Zaja, Francesco
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Results According to Age in Avex, a Randomized Phase 3 Trial of Bevacizumab with Capecitabine for Elderly Patients with Mcrc
Saunders, Mark, Lang, Istvan, Marcuello, Eugenio, Lorusso, Vito, Ocvirk, Janja, Jonker, Derek, Osborne, Stuart, Loeffler, Markus, Waterkamp, Daniel, Cunningham, David
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Efficacy and safety according to age subgroups in AVEX, a randomized phase III trial of bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer
Saunders, Mark P., Lang, Istvan, Marcuello, Eugenio, Lorusso, Vito, Ocvirk, Janja, Shin, Dongbok, Jonker, Derek J., Osborne, Stuart, Loeffler, Markus, Waterkamp, Daniel, Cunningham, David
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article